IntelGenx Technologies Corp.
IntelGenx Technologies Corp. operates as a drug delivery company. It focuses on the development of novel, orally administered drug delivery products based on its proprietary oral drug delivery technologies. The company is a provider of product development services for the pharmaceutical industry, including the branded and generic pharmaceutical markets. Its research and development pipeline includes products for the treatment of severe depression, hypertension, erectile dysfunction, benign prostatic hyperplasia, migraine, insomnia, bipolar disorder, idiopathic pulmonary fibrosis, allergies and pain management. The company was founded on July 27,1999 and is headquartered in Ville Saint-Laurent, Canada.